ResearcherUniversity of MissouriActive in the last 2 years

Paul de Figueiredo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3878-5064; OpenAlex author ID A5055894968; NIH RePORTER profile ID 8549154. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 1
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2026: 1 paper, 1 grant

Papers 1

CMTM6-Silencing Microbial Immunotherapy Reprograms PDAC Tumors and Restores T-cell Function Co-author DOI 10.64898/2026.01.26.701790 ↗

Grants 1

Tumor-Selective Bacterial Therapy to Reverse PDAC Immunosuppression R01CA314284 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chiswili Yves Chabu · 1 shared paper, 1 shared grant, 2026 · strength 1.49
- Grant Tumor-Selective Bacterial Therapy to Reverse PDAC Immunosuppression R01CA314284 ↗
- Paper CMTM6-Silencing Microbial Immunotherapy Reprograms PDAC Tumors and Restores T-cell Function DOI 10.64898/2026.01.26.701790 ↗
Bolni Marius Nagalo · 1 shared paper, 2026 · strength 0.23
- Paper CMTM6-Silencing Microbial Immunotherapy Reprograms PDAC Tumors and Restores T-cell Function DOI 10.64898/2026.01.26.701790 ↗
Omeed Moaven · 1 shared paper, 2026 · strength 0.23
- Paper CMTM6-Silencing Microbial Immunotherapy Reprograms PDAC Tumors and Restores T-cell Function DOI 10.64898/2026.01.26.701790 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.